Details:

Alternative Title:
Int J Tuberc Lung Dis
Publisher's site:
http://dx.doi.org/10.5588/ijtld.17.0003
Personal Author:
Wortham, Jonathan M. ; Goggin, Mary ; Mora, Carmen ; Vandehey, Linda ; Manangan, Lilia ; ... More +
Wortham, Jonathan M. ; Goggin, Mary ; Mora, Carmen ; Vandehey, Linda ; Manangan, Lilia ; Powell, Krista M. Less -
Description:
Treatment for latent tuberculous infection (LTBI) is a key strategy for the elimination of tuberculosis. Rare adverse reactions associated with LTBI treatment have been reported. We report the only case of acute kidney injury reported to Centers for Disease Control and Prevention surveillance for LTBI treatment-related adverse events. The patient experienced rapid intravascular hemolysis, resulting in heme pigment nephropathy; he was hospitalized and received three hemodialysis treatments, but recovered without sequelae. While LTBI treatment-related adverse events are rare, health care providers should maintain clinical vigilance and regularly counsel patients to facilitate prompt diagnoses and effective clinical management of affected patients.
Subject:
[+]
Acute Kidney Injury Adult Antibiotics, Antitubercular Article Hemodialysis Humans Kidney Injury Latent Tuberculosis Male Renal Dialysis Rifampin Tuberculosis Rifampin
Source:
Int J Tuberc Lung Dis. 21(5):596-597
Pubmed ID:
28399977
Pubmed Central ID:
PMC8968762
Document Type:
Journal Article
Funding:
CC999999/ImCDC/Intramural CDC HHSUnited States/
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:a4cf14e9bbfb13909cb35e703a9b9456e9dd974696cc5bb6fab4e23a5e016d74
Download URL:
https://stacks.cdc.gov/view/cdc/115865/cdc_115865_DS1.pdf
File Type:

Supporting Files

• nihms-1785565.nxml

  xml

More +